GLIMEPIRIDE Drug Patent Profile
✉ Email this page to a colleague
When do Glimepiride patents expire, and when can generic versions of Glimepiride launch?
Glimepiride is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Carlsbad, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma Llc, Hikma Pharms, Indoco Remedies, Micro Labs, Mylan, Norvium Bioscience, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Teva, and Watson Labs. and is included in seventeen NDAs.
The generic ingredient in GLIMEPIRIDE is glimepiride. There are sixteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glimepiride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glimepiride
A generic version of GLIMEPIRIDE was approved as glimepiride by CHARTWELL MOLECULAR on October 6th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLIMEPIRIDE?
- What are the global sales for GLIMEPIRIDE?
- What is Average Wholesale Price for GLIMEPIRIDE?
Summary for GLIMEPIRIDE
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 32 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Clinical Trials: | 231 |
| Patent Applications: | 4,165 |
| Drug Prices: | Drug price information for GLIMEPIRIDE |
| Drug Sales Revenues: | Drug sales revenues for GLIMEPIRIDE |
| DailyMed Link: | GLIMEPIRIDE at DailyMed |
See drug prices for GLIMEPIRIDE
Recent Clinical Trials for GLIMEPIRIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jiangsu Province Geriatric Institute | Phase 4 |
| Peking University People's Hospital | Phase 4 |
| Peking University First Hospital | Phase 4 |
Pharmacology for GLIMEPIRIDE
| Drug Class | Sulfonylurea |
Anatomical Therapeutic Chemical (ATC) Classes for GLIMEPIRIDE
US Patents and Regulatory Information for GLIMEPIRIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 077370-002 | Dec 23, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Micro Labs | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 091220-005 | Jun 29, 2012 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy Labs Ltd | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 076875-004 | Oct 6, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
